• Bioanalysis of chemical drugs
  • Biological analysis of biological products

Bioanalysis of chemical drugs

The platform is equipped with multiple advanced instruments, including LC-MS/MS, GC-MS/MS, ICP-MS, LC-HRMS and biosafety level II laboratorie. which specializes in the development, validation and sample analysis of bioanalytical methods for various chemical drugs andtheir metabolites, peptide drugs, small nucleic acid drugs, Antibody-drug Conjugates (ADCs) and metal elements, ensuring compliance with regulatory requirements. The platform provides accurate and reliable data support for studies such as bioequivalence studies for generic drugs and clinical pharmacokinetics of innovative drugs.

Biological analysis of biological products

The platform is equipped with multiple advanced instruments and facilities, such as microplate reader, MSD, flow cytometer, Real-Time PCR, biochemical analyzer, and facilities including cell laboratory, BSL-II laboratory and PCR laboratory. It is capable of carrying out development, validation and sample analysis for various types of researches such as monoclonal antibodies (mAbs), peptide, antibody-drug conjugates (ADCs), fusion protein vaccines, oncolytic viruses, gene therapy, cell therapy, and other related treatments, in compliance with regulatory requirements. The platform provides accurate and reliable data support for research in pharmacokinetics, immunogenicity, neutralizing antibodies, biomarkers, pharmacogenomics, and other related fields.